NXT_SLEEP - Next generation sleep monitoring platform
From 01-01-2013 to 31-12-2014
Website: http://www.iminds.be/en/research/overview-projects/p/detail/nxt_sleep
Description
"If sleep doesn't serve an absolutely vital function, then it is the greatest mistake the evolutionary process ever made" (Professor Emeritus Dr. Allan Rechtschaffen, University of Chicago)
We all spend 1/3 of our lives in bed and sufficient hours of good quality sleep in a regular daily rhythm is essential for our mental and physical well-being. Nevertheless, a significant part of the Belgian population experiences regular difficulties in sleeping, impacting their ability to socially interact, the quality of their work and proper judgement. We focus in this project on sleep-related breathing disorders, characterized by disruptions of normal breathing patterns that only occur during sleep such as snoring and sleep apnea, as they are recognized as major risk factors for mortality due to their effect on the cardiovascular system. The prevalence is around 4% in men and 2% in women.
Currently, these sleeping disorders are diagnosed using polysomnography (PSG), which is a sleep test that monitors different physiological signals such as heart rate, respiration, EEG, muscle tone and eye movement. This type of test needs to be performed in a sleep laboratory, under the supervision of an expert who attaches several electrodes to the patient. Although PSG is an important diagnostic tool for sleep medicine, it is an uncomfortable and costly procedure, especially when multiple nights of observation are required.
NXT_SLEEP will focus on the development of a next generation sleep monitoring platform that is less obtrusive and therefore more comfortable than the traditional polysomnography, allowing recordings for more than one night in a home environment, and using new sensors that deliver complete and useful information regarding the physiological parameters relevant for sleep-related breathing disorders.
Team
- Karin Slegers, Co-promoter (External)
- Paul Six, Co-promoter (External)
- Hans Druyts, Co-promoter (External)
- Romano Hoofman, Co-promoter (External)
- Steven Vandeput, Co-promoter
- Peter Vanvooren, Co-promoter (External)
- Rik Ryckbosch, Co-promoter (External)
- Olivier Braet, Co-promoter (External)
- Wilfried De Backer, Co-promoter (External)
- Sabine Van Huffel, Promoter
Financing
Funding: iMinds - Flanders' digital research center and incubator
Program/Grant Type: ICON - iMinds ICON
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.